Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1359287
                    [Title] => Drugmaker not ready to use Ebola drug
                    [Summary] => 
A Canadian drugmaker working on an experimental drug for Ebola said Wednesday that it is not ready to make the treatment available in Africa, despite assurances by international health officials that it is ethical to use untested treatments to fight the deadly outbreak.

                    [DatePublished] => 2014-08-19 00:00:00
                    [ColumnID] => 134176
                    [Focus] => 0
                    [AuthorID] => 1510056
                    [AuthorName] => Matthew Perrone, AP Health Writer
                    [SectionName] => Freeman Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

MAPP PHARMACEUTICALS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1359287
                    [Title] => Drugmaker not ready to use Ebola drug
                    [Summary] => 
A Canadian drugmaker working on an experimental drug for Ebola said Wednesday that it is not ready to make the treatment available in Africa, despite assurances by international health officials that it is ethical to use untested treatments to fight the deadly outbreak.

                    [DatePublished] => 2014-08-19 00:00:00
                    [ColumnID] => 134176
                    [Focus] => 0
                    [AuthorID] => 1510056
                    [AuthorName] => Matthew Perrone, AP Health Writer
                    [SectionName] => Freeman Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Drugmaker not ready to use Ebola drug

By Matthew Perrone, AP Health Writer | August 19, 2014 - 12:00am

A Canadian drugmaker working on an experimental drug for Ebola said Wednesday that it is not ready to make the treatment available in Africa, despite assurances by international health officials that it is ethical...

Freeman Opinion